87 related articles for article (PubMed ID: 15603987)
1. Management quandary. Case 2005: Ovarian suppression with chemotherapy in adolescents.
Blumenfeld Z
J Pediatr Adolesc Gynecol; 2004 Dec; 17(6):413-6. PubMed ID: 15603987
[No Abstract] [Full Text] [Related]
2. Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
Sinha R; Dionne JM
Arch Dis Child; 2008 May; 93(5):444-5. PubMed ID: 17908713
[No Abstract] [Full Text] [Related]
3. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
[TBL] [Abstract][Full Text] [Related]
4. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
Manger K; Wildt L; Kalden JR; Manger B
Autoimmun Rev; 2006 Apr; 5(4):269-72. PubMed ID: 16697968
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy].
Yang XY; Zhu X; Liang LQ; Zhan ZP; Ye YJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):960-2. PubMed ID: 16061002
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
Imai A; Furui T
J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
[TBL] [Abstract][Full Text] [Related]
7. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract][Full Text] [Related]
8. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
[TBL] [Abstract][Full Text] [Related]
9. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
[TBL] [Abstract][Full Text] [Related]
10. Are gonadotropin-releasing hormone analogs safe and effective for protection of ovarian reserve against chemotherapeutic insult?
Sönmezer M; Taşçi T; Gözüküçük M
Gynecol Endocrinol; 2008 Feb; 24(2):64-5; author reply 66. PubMed ID: 18210327
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy for premenopausal patients with early breast cancer.
Kurebayashi J
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):51-4. PubMed ID: 18197006
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
[TBL] [Abstract][Full Text] [Related]
13. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
Peccatori F; Demeestere I
Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
[No Abstract] [Full Text] [Related]
14. Chemotherapy and amenorrhea: risks and treatment options.
Oktay K; Sönmezer M
Curr Opin Obstet Gynecol; 2008 Aug; 20(4):408-15. PubMed ID: 18660694
[TBL] [Abstract][Full Text] [Related]
15. Resumption of ovarian function 20 years after chemotherapy-induced ovarian failure: a case report.
Longway M; Matthews CA
Fertil Steril; 2009 Jul; 92(1):392.e17-8. PubMed ID: 19403127
[TBL] [Abstract][Full Text] [Related]
16. Premature ovarian "failure" in the adolescent.
Rebar RW
Ann N Y Acad Sci; 2008; 1135():138-45. PubMed ID: 18574219
[TBL] [Abstract][Full Text] [Related]
17. Do GnRH analogs protect against ovarian toxicity of chemotherapy?
Moore HC
Breast Cancer Res Treat; 2009 Oct; 117(3):569-70. PubMed ID: 19234783
[No Abstract] [Full Text] [Related]
18. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Blumenfeld Z; von Wolff M
Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
[TBL] [Abstract][Full Text] [Related]
19. Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction.
Cejtin HE; Kalinowski A; Bacchetti P; Taylor RN; Watts DH; Kim S; Massad LS; Preston-Martin S; Anastos K; Moxley M; Minkoff HL
Obstet Gynecol; 2006 Dec; 108(6):1423-31. PubMed ID: 17138776
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?
Wetzels JF
Neth J Med; 2004 Nov; 62(10):347-52. PubMed ID: 15683089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
